Detalhe da pesquisa
1.
Proteasome-associated cysteine deubiquitinases are molecular targets of environmental optical brightener compounds.
J Cell Biochem
; 120(8): 14065-14075, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963630
2.
ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.
NAR Cancer
; 5(1): zcac045, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644397
3.
In Vivo Targeting Replication Protein A for Cancer Therapy.
Front Oncol
; 12: 826655, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35251993
4.
HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer.
DNA Repair (Amst)
; 87: 102802, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31981740
5.
APOBEC3 enzymes mediate efficacy of cisplatin and are epistatic with base excision repair and mismatch repair in platinum response.
NAR Cancer
; 2(4): zcaa033, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33196045
6.
Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents.
Recent Pat Anticancer Drug Discov
; 14(2): 113-132, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31084595
7.
Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition.
Future Med Chem
; 10(17): 2087-2108, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30066579